Q1 2026 Earnings Show Significant Decline, Increased Non-Accruals, Offset by Favorable Credit Facility Amendment & New Share Buyback Authorization
summarizeSummary
Goldman Sachs BDC, Inc. reported a significant drop in Q1 2026 earnings and a rise in non-accrual investments, but also announced a favorable amendment to its credit facility and a new $75 million share repurchase authorization.
check_boxKey Events
-
Significant Decline in Q1 2026 Financial Performance
Net investment income after taxes decreased to $24.79 million in Q1 2026 from $49.61 million in Q1 2025. The company reported a net loss from operations of $(13.63) million, a significant reversal from a net increase of $31.55 million in Q1 2025. Basic and diluted earnings per share swung to $(0.12) from $0.27 year-over-year.
-
Increase in Non-Accrual Investments
Non-accrual investments at amortized cost increased to $161.30 million (4.7% of total investments) as of March 31, 2026, up from $95.80 million (2.8% of total investments) as of December 31, 2025. The percentage of Grade 4 (highest risk) investments also slightly increased to 2.7% from 2.3%.
-
Favorable Revolving Credit Facility Amendment
The company entered into a Fifteenth Amendment to its Senior Secured Revolving Credit Agreement on May 5, 2026. This amendment extends the final maturity date to May 5, 2031, reduces the applicable interest margin, removes credit adjustment spreads, increases swingline and letter of credit sublimits, and lowers commitment fees.
-
New Share Repurchase Program Authorized
The Board of Directors approved and authorized an additional 10b5-1 stock repurchase program for up to $75 million of common stock. This program is expected to commence once the existing 2025 10b5-1 Plan is fully utilized or expires.
auto_awesomeAnalysis
Goldman Sachs BDC, Inc. reported a substantial decline in its first-quarter 2026 financial performance, with net investment income after taxes nearly halving and a shift from net income to a net loss from operations. This deterioration is further underscored by a significant increase in non-accrual investments, indicating rising credit risk within the portfolio. However, the company has proactively managed its capital structure by amending its Revolving Credit Facility, securing more favorable terms including extended maturities and reduced interest margins. Additionally, the authorization of a new $75 million share repurchase program signals management's confidence in the company's intrinsic value, potentially offering support for the stock price. Investors should monitor the trend in non-accrual investments and the impact of the new credit facility terms on future profitability.
At the time of this filing, GSBD was trading at $9.81 on NYSE in the Unknown sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $8.66 to $12.03. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.